Eight Advisory team assisted Gedeon Richter in their investment in Mithra assets Estetra and Neuralis 

Gedeon Richter is a global group of companies specialising in the production of medicines and medicinal products. 

Mithra is a company dedicated to women’s health. Its key asset is its own-developed lead platform, based on Estetrol (E4), a unique, native estrogen. The transaction aims to acquire exclusive rights of this molecule for multiple indications and several synthetic approaches thereof, as well as worldwide rights attached to the linked product/product candidates. 

The acquired assets represent a unique opportunity for Richter to further expand and deepen its presence in its core Women’s Healthcare (WHC) business worldwide. 

Congratulations to all involved parties and big thanks to our team: 

• Financial Due diligence: Philippe Fimmers (Partner), Joris Peers (Director), Caroline Depestel (Senior Manager), Fábio Gonçalves Viegas (Senior Manager), Alain Kabera (Senior), Carl Couvreur (Analyst)

• Tax due diligence: Christian Van Craeyvelt (Partner), Jean-Louis Vansimaeys (Manager), Ward Sandra (Analyst)